A Biophysical Systems Approach to Identifying the Pathways of Acute and Chronic Doxorubicin Mitochondrial Cardiotoxicity
Fig 3
Normalized dynamic variation of mitochondrial function to different doses of DOX.
Time varying concentrations of DOX following the drug’s pharmacokinetics were used as an input. The resulting variation in different measurements of mitochondrial function can be observed.